Author: Shields, Adrian; Faustini, Sian E; Perez-Toledo, Marisol; Jossi, Sian; Aldera, Erin; Allen, Joel D; Al-Taei, Saly; Backhouse, Claire; Bosworth, Andrew; Dunbar, Lyndsey A; Ebanks, Daniel; Emmanuel, Beena; Garvey, Mark; Gray, Joanna; Kidd, I Michael; McGinnell, Golaleh; McLoughlin, Dee E; Morley, Gabriella; O'Neill, Joanna; Papakonstantinou, Danai; Pickles, Oliver; Poxon, Charlotte; Richter, Megan; Walker, Eloise M; Wanigasooriya, Kasun; Watanabe, Yasunori; Whalley, Celina; Zielinska, Agnieszka E; Crispin, Max; Wraith, David C; Beggs, Andrew D; Cunningham, Adam F; Drayson, Mark T; Richter, Alex G
Title: SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study Cord-id: leqluxpl Document date: 2020_8_28
ID: leqluxpl
Snippet: OBJECTIVE: To determine the rates of asymptomatic viral carriage and seroprevalence of SARS-CoV-2 antibodies in healthcare workers. DESIGN: A cross-sectional study of asymptomatic healthcare workers undertaken on 24/25 April 2020. SETTING: University Hospitals Birmingham NHS Foundation Trust (UHBFT), UK. PARTICIPANTS: 545 asymptomatic healthcare workers were recruited while at work. Participants were invited to participate via the UHBFT social media. Exclusion criteria included current symptoms
Document: OBJECTIVE: To determine the rates of asymptomatic viral carriage and seroprevalence of SARS-CoV-2 antibodies in healthcare workers. DESIGN: A cross-sectional study of asymptomatic healthcare workers undertaken on 24/25 April 2020. SETTING: University Hospitals Birmingham NHS Foundation Trust (UHBFT), UK. PARTICIPANTS: 545 asymptomatic healthcare workers were recruited while at work. Participants were invited to participate via the UHBFT social media. Exclusion criteria included current symptoms consistent with COVID-19. No potential participants were excluded. INTERVENTION: Participants volunteered a nasopharyngeal swab and a venous blood sample that were tested for SARS-CoV-2 RNA and anti-SARS-CoV-2 spike glycoprotein antibodies, respectively. Results were interpreted in the context of prior illnesses and the hospital departments in which participants worked. MAIN OUTCOME MEASURE: Proportion of participants demonstrating infection and positive SARS-CoV-2 serology. RESULTS: The point prevalence of SARS-CoV-2 viral carriage was 2.4% (n=13/545). The overall seroprevalence of SARS-CoV-2 antibodies was 24.4% (n=126/516). Participants who reported prior symptomatic illness had higher seroprevalence (37.5% vs 17.1%, χ(2)=21.1034, p<0.0001) and quantitatively greater antibody responses than those who had remained asymptomatic. Seroprevalence was greatest among those working in housekeeping (34.5%), acute medicine (33.3%) and general internal medicine (30.3%), with lower rates observed in participants working in intensive care (14.8%). BAME (Black, Asian and minority ethnic) ethnicity was associated with a significantly increased risk of seropositivity (OR: 1.92, 95% CI 1.14 to 3.23, p=0.01). Working on the intensive care unit was associated with a significantly lower risk of seropositivity compared with working in other areas of the hospital (OR: 0.28, 95% CI 0.09 to 0.78, p=0.02). CONCLUSIONS AND RELEVANCE: We identify differences in the occupational risk of exposure to SARS-CoV-2 between hospital departments and confirm asymptomatic seroconversion occurs in healthcare workers. Further investigation of these observations is required to inform future infection control and occupational health practices.
Search related documents:
Co phrase search for related documents- acute medicine and logistic regression analysis: 1, 2, 3
- acute medicine and longitudinal study: 1
- local government and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- local government and logistic regression analysis: 1, 2, 3, 4, 5, 6
- local government and longitudinal study: 1, 2, 3, 4, 5
- local government communities and longitudinal study: 1
- logistic regression analysis and longitudinal study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- logistic regression analysis and low seroprevalence: 1
- logistic regression and longitudinal study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- logistic regression and low seroprevalence: 1, 2, 3, 4
- logistic regression model and longitudinal study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- logistic regression model and low seroprevalence: 1
Co phrase search for related documents, hyperlinks ordered by date